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Abstract
Background: Literature documents the high prevalence of trauma and posttraumatic stress disorder (OTSD) in individuals with
substance use disorders, which complicate the clinical profile of patients and present challenges for treatment providers. Although
several evidence-based integrated therapies are developed for comorbid PTSD/SUD (substance use disorder), there is a considerable
gap addressing this co-occurrence and none of such practices are studied yet on such patients. Through A-B-A single subject design.
Objectives: The current study aimed to explore the effectiveness of seeking safety (SS), an integrative evidence-based therapy for
PTSD/SUD, to reduce PTSD and SUD symptoms in a 32-year-old female with both disorders.
Patients and Methods: Measures of PTSD checklist (PTSD Checklist_Civilian; PCL-C), Addiction Severity Index (ASI), Brief Symptom
Inventory (BSI), and Coping Inventory for Stressful Situations (CISS-21) were completed by the participant at baseline, intervention,
and 2-month follow-up.
Results: Results were analyzed through visual analysis and computing 3 effect size indices including standardized mean difference
(SMD), mean baseline reduction (MBLR), and percent of non-overlapping data (PND).
Conclusions: Clinically significant reductions in PTSD symptoms, psychological distress, and ASI scores, as well as improvement
in coping skills were observed at intervention phase and maintained at 2-month follow-up, which indicated that the participant
benefited from SS.
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1. Background
Comorbidity research consistently shows high co-
occurrence of posttraumatic stress disorder (PTSD) and
substance use disorder (SUD) in both clinical and general
population (1). In the drug treatment settings, the comor-
bid PTSD/SUDs is associated with more substance-related
problems. During the treatment of SUD, individuals with
comorbid PTSD/SUD are at higher risk for relapse (2), have
lower rates of remission from SUD, and higher ongoing
negative consequences of their substance use (3). In ad-
dition, comorbid SUD/PTSD is associated with worse physi-
cal health outcomes versus having SUD without PTSD (4) or
PTSD without SUD (5). Co-occurrence of both PTSD and SUD
is also associated with greater financial strain, unemploy-
ment, and likelihood of suicide attempts, compared with
the occurrence of either disorder alone (6).
Drug treatment providers usually apply a sequen-
tial treatment approach to individuals with comorbid
PTSD/SUD that is treating the addiction first, and then, ad-
dressing the PTSD, when the abstinence is achieved. In
such approaches, clients with histories of SUD and trauma
might be overlooked in treatment settings due to the com-
plexity of their issues, or may receive treatment for one
issue, while the other issue remains unaddressed, which
may contribute to poorer outcomes and higher costs (7).
Emerging research shows that an integrated approach ad-
dressing both disorders simultaneously by the same prac-
titioner is the best approach (8). Such an approach allows
for addressing both disorders adequately, and provides the
opportunity for the clients to understand how these disor-
ders might be linked.
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Moreover, the research suggests that an integrated ap-
proach is often more successful both in short and long
term, more cost-effective, and more sensitive to the unique
needs of clients (8), and failing to provide an integrated
treatment may lead to negative outcomes such as inabil-
ity to achieve prolonged periods of stability with respect to
substance abuse or trauma symptomology. Part of this in-
ability is attributable to clients’ lack of knowledge about
how to deal with trauma symptoms once their primary
coping mechanism (i e, drugs or alcohol use) is removed
(9).
Seeking Safety (10) (SS) is an integrated manualized
treatment program that teaches cognitive, behavioral, and
interpersonal skills focused broadly on increasing females’
skills to establish safety including safety of substances, im-
proving interpersonal skills to help them disengage from
unsafe relationships (i e, domestic violence and substance-
using friends), and developing better emotion regulation,
and coping skills to avoid extreme psychological and be-
havioral complications such as dissociation and self-harm
(11). The SS protocol is a detailed treatment manual with
25 separate sessions. SS is designed as the first stage re-
covery from both disorders and does not focus on emo-
tional processing through exposure technique. SS is also
one of the most studied integrated treatments for comor-
bid PTSD/SUD, and is evidence-based.
2. Objectives
Due to the considerable gap in addressing co-
occurrence of PTSD and SUD in treatment settings in
Iran. The current study aimed to investigate the effective-
ness of SS on the treatment outcome in a patient with
comorbid PTSD/SUD.
3. Patients and Methods
3.1. Procedure
An A-B-A single subject design was applied to assess the
effectiveness of SS for a patient with comorbid PTSD/SUD.
Initial interview was conducted using a structured
clinical interview for diagnostic and statistical manual of
mental disorders, 4th edition (DSM-IV) and structured clin-
ical interview for DSM-IV axis I disorders (SCID-I), as a part
of screening process of the psychological status of patients
in a residential treatment center. Patients with comor-
bid SUD/PTSD were invited to participate in a SS treatment
program voluntarily. A written informed consent was ob-
tained; then, the recruited participant completed 3 base-
line assessments by a 2-week interval. The first assessment
was conducted when she resided in the center, and 2 other
assessments were conducted after her discharge. After
completion of baseline assessments, biweekly personal SS
treatment sessions were provided by a trained PhD stu-
dent of clinical psychology (SJ). Therapist had the certifi-
cate of SS exam and received the clinical supervision certifi-
cate from a trained, PhD level, assistant professor of clini-
cal psychology (FL). During 12 weeks of intervention, 6 as-
sessments of ASI by 2-week interval and 8 assessments of
other measures by 10-day interval were completed. Follow-
up included 3 assessments by 2-week interval. During the
study, the patient received no other treatments. Study as-
sessments were conducted by the study therapist.
Data analysis was conducted through computing 3 ef-
fect size indices for case study designs including stan-
dardized mean difference (SMD), mean baseline reduction
(MBLR), and percent of non-overlapping data (PND).
The values of SMD≥ 0.8, SMD = 0.5 - 0.8, and SMD < 0.5
respectively indicated the powerful, moderate, and weak
effect of the intervention. MBLR is applicable when the
purpose of intervention is to reduce the dependent vari-
ables. PND represents the percent of data improvement in
the subsequent phase compared with previous phase. The
results of visual data analysis were also provided by inter-
and intra-relationships of the variables including mean,
median, range, trend, and relative and absolute changes of
dependent variables.
The study protocol was approved by the research ethics
committee of Iran University of Medical Sciences (IUMS),
Tehran, Iran.
3.2. Case Presentation
The patient was a 32-year-old and divorced female; she
had been stayed in the residential drug treatment center
for 20 days when she was first interviewed by the therapist.
She had 14 years education. At the time of intake, she was
living with her 60-year-old uncle who was an alcohol user.
She was unemployed and financially dependent on her un-
cle. She had a 6-year-old daughter, but had no connection
with her. Her social support network was so limited and
had no intimate non-drug user friend, no connection with
her siblings, and limited connection with her mother via
social networks.
3.3. History and Presenting Complaints
She was the second child with 2 sisters and 1 brother.
She reported a normal life until she was 17, when her 12-
year-old sister died due to the car accident in front of her
eyes. Other family members were in the car and had seri-
ous injuries, but survived.
This accident affected the family intensely; her mother
blamed her father for the accident and her father was so
depressed that quitted his work and got retired early.
2 Int J High Risk Behav Addict. 2018; 7(2):e58980.
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She tried to avoid this tension by smoking alone at
her room. At 19 she started occasional use of metham-
phetamine in parties and at home, but when her parents
divorced and the father left them to live in another city, she
increased her substance use and left the university at 20.
Her mother immigrated to the United States when she
was 21 and she felt deep loneliness since she had limited
connection with her married sister and younger brother
who did not approve her lifestyle. Since then, she spent
most of her times with her boyfriend and started daily use
of methamphetamine and cannabis.
She started using alprazolam and lorazepam at the age
of 22 and kept using until the age of 27. She also started
cocaine use at 23 and kept using it daily for 2 years.
She reported that using substance was a way to forget
the miseries of life and feel more energetic. She also en-
joyed getting high with friends and felt more connected.
She got pregnant at 27 and married her boyfriend, but
after giving birth to her child, she left them. Her family
rejected her when she tried to make new connection with
them and she moved to live with her uncle.
Although she had used diverse substances, her main
problem was using methamphetamine and cannabis. She
had tried to quit using drugs twice, but she could not main-
tain abstinence more than 1 week.
She had decided to enter drug treatment since she was
tired of current situation and she hoped to connect with
her family after achieving abstinence.
3.4. Measures
SCID-I for axis I and II disorders were applied only at
first interview to screen patient for other comorbid disor-
ders. Following measures were applied at baseline, and
other study assessments.
PTSD checklist-civilian (12): The severity of PTSD symp-
toms was assessed using PCL-C, which is a self-report mea-
sure consisting of 17 items assessing symptoms of PTSD and
the extent to which the respondent experienced each of
them during the last month. The Persian version of PCL-C
has good reliability and validity (13).
Addiction severity index (14): A semi-structured inter-
view that assesses 7 potential problem areas commonly af-
fected by drug and alcohol dependence was used to assess
the current status of the patient in terms of medical sta-
tus, employment status, legal problems, family-social rela-
tions, drug use, alcohol use, and psychiatric status. The Per-
sian version of ASI has high reliability and validity (15).
Brief symptom inventory (16): The 53-item self-report
symptom inventory assesses 9 symptom dimensions in-
cluding anxiety, depression, phobia, paranoid ideation, ob-
session, somatization, psychoticism, interpersonal sensi-
tivity, and hostility. It also provides a global index of dis-
tress (GSI). The Persian version of BSI has good validity and
reliability (17). The current study used the most valid scales
of BSI including anxiety, depression, and GSI to assess psy-
chological distress of the patient.
Coping Inventory for Stressful Situations-short form
(18): It is a 21-item self-report questionnaire, which mea-
sures problem, emotion, and avoidance-oriented copings.
This measure also showed good reliability and validity in
the Iranian population (19). CISS was used to assess the cop-
ing style of the patient and its changes throughout the in-
tervention.
3.5. Initial Assessment
Based on SCID-IV for axis I and II disorders, the patient
was diagnosed with current PTSD, which appeared first
when she was 17 years old and was associated with the mor-
tal accident and death of her sister.
PCL showed high severity of PTSD symptoms. The
avoidance symptoms had the highest score; then, intru-
sion and arousal respectively had high scores at baseline.
She was also diagnosed with current metham-
phetamine and cannabis dependence, and showed
the lifetime evidence of cocaine and anxiolytic depen-
dence. Her test results were positive for cannabis and
methamphetamine when she first entered the treatment
center.
ASI showed problems in drug use, family relationships,
employment, and psychiatric areas. She reported symp-
toms of despair, anxiety, and tension, which caused dis-
tress; and she reported that managing them was of great
importance to her.
On CISS, she showed highest score for emotional cop-
ing and then, avoidance through employing distraction
techniques. She barely used problem-oriented copings
and using drugs was the main strategy for her to relieve
from emotional pain or forgetting problems.
3.6. Treatment Process
Treatment took place during 12 weeks, including 24 ses-
sions (90 minutes) biweekly. Initial sessions of this ther-
apy are essential due to the atmosphere of trust, thera-
peutic alliance, and validating patient emotions and con-
cerns that should be established and maintained through-
out the treatment in which the patient takes the main re-
sponsibility of her own treatment.
In the first session, the treatment was introduced to
the patient and she was encouraged to provide her con-
cerns and questions about this treatment. Case manage-
ment needs of the patient were also assessed and discussed
until a list of needs were prepared.
Her uncle was a heavy alcohol user and offered drugs
to her; therefore, she decided to have the least contact with
Int J High Risk Behav Addict. 2018; 7(2):e58980. 3
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him. She also decided to stay at residential center for 2 days
of each weekend. She had no safe activity for leisure time,
and finding a source of financial support was among her
primary needs. The therapist and patient agreed to work
on these issues during the treatment process. Maintain-
ing abstinence, connecting with at least 1 family member,
coping with negative emotions without using substance,
and increasing safe and healthy activities were listed as pa-
tient’s goals to be achieved at the end of treatment.
Session 2 focused on the concept of safety as the first
stage of recovery, identifying safe and unsafe coping skills,
and the importance of using safe coping skills in any situ-
ations.
The meaning of safety for the patient was also dis-
cussed; she considered the safety as one of treatment goals
and introduced safety as living with family in a safe home
with no drugs and least tension, being protected from un-
safe relationships, and asking help whenever necessary.
Session 3 focused on psycho-education about PTSD and
the link between PTSD and substance use. The patient was
asked to identify how her PTSD symptoms and substance
use were related. She reported how using substances such
as cocaine and especially methamphetamine helped her to
feel energetic and forget bad feelings; she also recognized
how doing self-destructive behaviors such as cutting her
hand helped her to decrease her pain. She recognized her
substance use as the main cause of losing her family, which
in turn caused feeling worse and using more substances.
She confirmed that learning new ways of coping with neg-
ative emotions may help her to safely manage her feelings.
She also learned how to use a technique to decrease
emotional pain named grounding, which helped the pa-
tient to distract focus from intrusive thoughts to neutral
aspects of the environment.
The following sessions mainly focused on psycho-
education about both PTSD and substance use, defining
the disorders, discussing how substance abuse prevented
the patient from healing of PTSD, choosing a way to quit
substance use, planning to maintain abstinence, and us-
ing safe coping skills such as how to ask for help, how to
use compassionate self-talk instead of self-blaming, taking
care of herself, identifying dangerous situations and plan-
ning safety procedures, problem solving, and anger man-
agement.
With the progress of treatment, more cognitive top-
ics such as maladaptive thinking related to PTSD and sub-
stance use, setting boundaries in relationships, and dis-
tinguishing safe relationships from unsafe ones were dis-
cussed.
In each session, the patient was encouraged to start a
discussion on her issues and explain how these new skills
may help her.
Some sessions were critical in the treatment. In session
6, the patient came up with a metaphor of her own used
during the treatment sessions effectively; she suggested
that using substances is similar to being numb when you
are walking with bare feet on the road of broken glasses
leading to nowhere; you feel no pain, but you are dam-
aging yourself with walking on unsafe road without pro-
tection. This metaphor came to her mind when she read
the handout, which analogized the recovery process with
climbing a mountain; although it is hard, it worth trying.
At session 8, finally the therapist could contact the pa-
tient’s brother, the only accessible family member, and he
agreed to cooperate after 2 sessions discussing the patient
conditions. She moved to live with her brother at session
16. Although she was excited at first, after a while some
new negative thoughts such as being useless and weak
compared with her brother, and losing her independency
raised. These thoughts were discussed with cognitive tech-
niques and then, she was encouraged to identify how she
can cope safely with these thoughts based on what she had
learned. Extra sessions were also held with her brother
since he did not know how to treat the patient, and he had
his own concerns.
She also had an unrealistic goal to reconnect her par-
ents together and she thought this is the only way for her to
heal. After validating her feelings and her need for family
support, she was reminded that she can only set personal
goals that can be accomplished merely by herself; and
then, by the cognitive techniques she realized the mean-
ing of such demand for herself and set more realistic goals,
which were achievable.
Urine analysis was taken before each session and she
was abstinent during the treatment period and follow-up.
At the end of the treatment, the patient was living with
her brother; she was planning a trip to her father’s home
for New Year vacations, and was starting a part-time job
as a roller skate coach, which was her previous job for 2
years. Again, she had new anxieties about encountering
her dad, reminding of a broken family, and the absence
of her mother. The last session was devoted to these situ-
ations and both the therapist and patient provided some
imaginary scenarios, and patient was encouraged to de-
scribe how she can cope safely with these situations.
During the follow-up stage, patient continued her con-
tact with therapist in case she needed help. Although this
contact may obscure the results, for ethical reasons and
considering the limited sources that were accessible to the
patient, this connection was preserved; however, there was
not a formal intervention session. On the other hand, this
connection might be considered as a positive treatment
outcome.
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4. Results
The visual analysis of data, as well as the effect size in-
dices for dependent variables are presented at Tables 1 and
2, which indicate powerful effect of intervention to reduce
PTSD symptoms (SMD = -8.9), GSI (SMD = -4.21), drug use
(SMD = -0.85), family relationships (SMD = -11.84), psychi-
atric status (SMD = -4.12), and improvement of coping skills
in terms of more problem-oriented (SMD = 9.2) and less
emotion-oriented coping strategies (SMD = -6.0) at inter-
vention phase. Avoidance-oriented coping strategies also
increased (SMD = 1.5), although it was based on the treat-
ment purposes in which the strategy of avoidance changed
with avoiding dangerous situations, contacting therapist,
and replacing drug use with more safe avoidance and dis-
traction techniques. Occupational status of the patient
showed an improvement at follow-up phase (PND = 66%).
5. Discussion
It was the first study assessing an integrated evidence-
based treatment for both PTSD and SUD in Iran and showed
how applying an integrated treatment can improve the
treatment outcome.
The results showed that the patient could benefit from
this treatment. At the end of each session, the patient was
asked to say what part of the session was more helpful for
her, and she expressed the following elements: knowing
more about the problems she was experiencing and the
link between them, the supportive and respectful struc-
ture of the therapy, which was different from other treat-
ment settings, feeling that someone cares about her, being
compassionate to herself, understanding about the mal-
adaptive thoughts and behaviors developed during these
years and the opportunity for change, having some exter-
nal force, which made her control herself when she felt
craving (urine analysis), and her family support, which
helped her to maintain her motivation for change in dif-
ficult situations.
Patients with SUD often experience problems in differ-
ent areas of function and often lack enough skills to man-
age such problems. Maintaining abstinence without ad-
dressing these diverse problems, if not impossible, is so
hard. Comorbid disorders including PTSD increase this
complexity. SS offers a wide variety of treatment topics cov-
ering basic as well as more complicated needs of such pa-
tients in different areas. In addition, the employed struc-
tured, motivational, and supportive approach provided
the patient with predictability, sense of control, and safety
that can facilitate the therapeutic alliance and help the pa-
tient to take the responsibility for her recovery.
The importance of case management needs of pa-
tients, especially those of females, was an implication of
the current study. Without helping patients with their ba-
sic needs, they cannot move toward recovery. Therefore, as-
sessing and addressing such needs should be considered
seriously by treatment providers.
The results of the current study were consistent with
that of previous research (20) and suggested that SS can be
used effectively in patients with both PTSD and SUD disor-
ders.
The current study had some limitations. The first as-
sessment in baseline was done at residential treatment
center and 2 other assessments were conducted after pa-
tient’s discharge. The PTSD symptoms and psychological
distress score were so high at the first assessment and re-
duced after her discharge, which necessitated more assess-
ments to get a stable trend. But, due to ethical and practi-
cal issues it was not possible to wait for more assessments;
however, she had the same scores at the 2 last baseline as-
sessments.
Lack of control over the participant to address external
validity threats was another limitation. Further investiga-
tions with randomized controlled trials are needed to gen-
eralize such results to Iranian population.
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